Grants.gov listing

ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV

<p>NICHD will advance its mission by using the DP2 mechanism to support early-career investigators conducting pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C).

National Institutes of HealthFederal GrantSolicitation PAR-26-105

Analyze This Opportunity in CaptureIQ

Compare your company's capabilities against this federal opportunity using CaptureIQ.

Ready to Pursue This Opportunity?

Qualify the fit, analyze competitors, identify teaming partners, and generate review-ready materials — all in CaptureIQ.

  • Federal capture workflow
  • Competitor & teaming intelligence
  • Proposal preparation

Opportunity details

Notice type
Federal Grant
Original posted
February 6, 2026
Last updated
November 2, 2026
Notice ID
grant-361255

Summary

NICHD will advance its mission by using the DP2 mechanism to support early-career investigators conducting pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C). Scientific directions will be distinct from concepts and approaches already pursued and consistent with the scientific priorities of the Office of AIDS Research (OAR). HIV-related 3Cs cause significant and different pathology in people with and without HIV. Development of preventive and therapeutic strategies based on understanding HIV-specific pathways and mechanisms, and implementing those strategies is critical, especially in pediatric and maternal populations. All pediatric and maternal populations will be appropriate for study as the focus is on HIV prevention and/or treatment research. A pipeline of innovative researchers from other fields of research including mathematics, engineering, computer science, and AI will bring new ideas and innovative approaches. This NOFO will advance research on an important public health problem by supporting transformative research on HIV 3Cs by investigators in the early stages of an independent career.

Read Full Official Summary

NICHD will advance its mission by using the DP2 mechanism to support early-career investigators conducting pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C). Scientific directions will be distinct from concepts and approaches already pursued and consistent with the scientific priorities of the Office of AIDS Research (OAR). HIV-related 3Cs cause significant and different pathology in people with and without HIV. Development of preventive and therapeutic strategies based on understanding HIV-specific pathways and mechanisms, and implementing those strategies is critical, especially in pediatric and maternal populations. All pediatric and maternal populations will be appropriate for study as the focus is on HIV prevention and/or treatment research. A pipeline of innovative researchers from other fields of research including mathematics, engineering, computer science, and AI will bring new ideas and innovative approaches. This NOFO will advance research on an important public health problem by supporting transformative research on HIV 3Cs by investigators in the early stages of an independent career.

Summary fields are from official SAM.gov or Grants.gov structured data. CaptureIQ does not republish full solicitation or grant text.

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Eligible applicant categories

  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • Private institutions of higher education
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Public and State controlled institutions of higher education
  • County governments
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
  • State governments
  • Independent school districts
  • Small businesses
  • For profit organizations other than small businesses
  • Special district governments
  • Public housing authorities/Indian housing authorities
  • City or township governments
  • Native American tribal governments (Federally recognized)
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Official Grants.gov eligibility information. Listed categories are not a determination that an organization qualifies.

Funding and program

Assistance Listing
93.865
Funding instrument
Grant
Cost sharing
Not required
Estimated total program funding
1,960,000
Expected number of awards
4 (government estimate, not a guaranteed count)
Official modification date

Estimated total program funding is the government figure for the whole program, not an individual award ceiling. The expected number of awards is a government estimate, not a guaranteed count. These figures are estimates, not guaranteed funding.

Related Federal Opportunities

Why this matters

  • This notice is a federal grant.
  • 4 related opportunities are from this agency.

Market context

4 Related OpportunitiesMatching opportunities on RFPCapture

Related intelligence

Research and capture tools

Contextual RFPCapture research and free tools related to this public federal page.

← All federal opportunities · Federal Opportunity Research

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.